Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Observational Study to Identify Different Prognostic Factors Related to Survival in Patients With Previously Treated Advanced NSCLC With Wild-type Epidermal Growth Factor Receptor (EGFR) Gene.

NCT01512420 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01512420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01512420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Observational Study to Identify Different Prognostic Factors Related to Survival in Patients With Previously Treated Advanced NSCLC With Wild-type Epidermal Growth Factor Receptor (EGFR) Gene.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
February 28, 2015
Enrollment
355 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

non-squamous non-small cell lung cancer